MSU AI Accelerates Drug Discovery for Cancer

Researchers at Michigan State University have developed a new deep-learning system to accelerate drug discovery ^[1]. The AI-driven approach predicts how various chemical structures influence gene expression within cells ^[1][2]. This study was published in the journal Cell ^[1]. ## AI Targets Liver Cancer and Lung Disease The system has already identified potential treatments for aggressive liver cancer and chronic lung disease ^[1][2]. This technology allows scientists to screen chemical compounds much faster than traditional laboratory methods ^[2]. By analyzing complex biological data, the AI suggests which drugs might be most effective for specific conditions ^[1].